BCAN's Patient Handbook - Bladder Cancer Basics for the Newly Diagnosed



Donate Now to Support the Bladder Cancer Advocacy Network



Join The Online Bladder Cancer Support Community



The Bladder Cancer Advocacy Network (BCAN) is proud to announce that we have been designated a Marine Corps Marathon (MCM) Charity Partner! BCAN has been allocated 25 guaranteed entries for the 38th Annual Marine Corps Marathon to be held on October 27, 2013; an event that sold out in 2 hours and 41 minutes in 2012.
  • We are looking at building “Team BCAN” to not only run in the event and raise awareness for bladder cancer but to raise needed funds for fostering research and patient education. According to the Marine Corps Marathon, there is not a required qualifying time to participate in the event, but all runners should maintain at least a 14 minute mile pace. In order to become a member of “Team BCAN” and officially have a slot in this year’s race, you must be registered through BCAN.
  • No federal or Marine Corps endorsement is implied.
  • If you are interested in becoming a member of BCAN’s team or have any questions, please contact Larry Rzepka, BCAN’s Executive Director, at lrzepka@bcan.org.
  • James McKiernan
    James McKiernan, M.D.
    Columbia University

    Dr. McKiernan graduated from Johns Hopkins University in 1989 with a B.A. in Biology and received his medical degree from Columbia University College of Physicians and Surgeons in 1993. He has remained affiliated with NewYork-Presbyterian/Columbia University Medical Center for the past 22 years, completing his training in urology and general surgery at the Medical Center in 1999. Dr. McKiernan then completed a two-year urologic surgical oncology fellowship studying at Memorial Sloan-Kettering Cancer Center.

    In 2001 Dr. McKiernan was appointed as Assistant Professor of Urology at Columbia University College of Physicians & Surgeons. In 2006 Dr McKiernan was named to the John and Irene Given endowed Chair in Urology and in 2007 was named Associate Professor of Clinical Urology and . In 2010 Dr McKiernan was promoted to Professor of Clinical Urology and has served as the Vice Chairman of Urology and Director of Urologic Oncology since 2006.

    Dr. McKiernan is actively involved in research and discovery with ongoing programs focused on improving patient clinical outcomes with bladder cancer. His research and discoveries have been published in Urology, Journal of Urology, Journal of Clinical Oncology, Urologic Oncology, British Journal of Urology, Cancer, and Cancer Research. He has authored and co-authored more than 135 scientific articles and book chapters in the field of Urologic Oncology. For the past 10 years he has directed the research efforts at Columbia University in outcomes and effectiveness research in urologic cancer surgery. In addition, Dr. McKiernan directs the experimental clinical trials program in intravesical therapy for drug resistant bladder cancer. This program has helped develop promising new agents for bladder preservation in patients whose cancer has recurred after the use of BCG therapy. In collaboration with the research scientists in the Herbert Irving Comprehensive Cancer Center this team continues to develop new therapeutic strategies for managing bladder cancer.

    Click here for more information.